TB Tx Flashcards

1
Q

Mycobacteria general resistance

A

slow growth
lipid rich mycobacterial cell wall
abundance of efflux pumps
quickly develop single-agent resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

latent TB (LTBI)

A

Isoniazid (INH) for 9 months
or
Rifapentine and INH for 3 months
or rifampin for 4 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

active disease

A

2-month initial phase

continuation phase of 4 or 7 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

initial therapy

A

INH
rifampin
pyrazinamide
ethambutol (once susceptibility of above confirmed drop this drug)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

risk for Tx failure

A

cavitary disease at presentation

positive sputum culture at 2 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

drug susceptible infection with 1 or no risk factors

A

continuation phase should be INH and rifampin for 4 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

both risk factors

A

continuation phase 7 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

TB osteomyelitis

A

6-9months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

TB menigitis

A

9-12 months

add corticosteroid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

TB pericarditis

A

add corticosteroid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

pyrazinamide added to INH-rifampin

A

only needed for 2 months
shortens Tx to 6 months
but pyrazinamide is most nephrotoxic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

resistance to INH

A

Tx w/rifampin, pyrazinamide, ethambutol

can add FQ

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

resistance to rifamycns

A

at least 12months of Tx with INH, ehtambutol, and FQ

pyrazinamide for 2 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

MDR and XDR

A

daily DOT therapy

INH, rifampin, ethambutol, pyrazinamide, aminoglycoside, FQ, PAS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

LTBI + HIV

A

daily INH for 9 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

active TB +HIV

A

INH
rifamycin
ethambutol
pyrazinamide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

ART +TB

A

rifampin largest drug interaction, inhibits ART

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

CD4 <50

A

initiate ART asap

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

CD4>50

A

wait until after initial phase of TB Tx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

LTBI + TNF alpha inhibitor

A

high risk for developing active TB

patients should always be screened for TB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

LTBI and prego

A

delay Tx for LTBI for 2-3 months after delivery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

active TB and prego

A

requires Tx b/c of risk of TB to fetus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

agents to avoid while Tx TB in prego

A

streptomycin -> deafness

kanamycin, amikacin, capreomycin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

1st line against TB

A
INH
rifampin
pyrazinamide
ethambutol
streptomycin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
INH
prodrug activated by KatG
26
INH MOA
complex w/KasA which inhibits synthesis of mycolic acids, a cell wall component, killing cell
27
INH resistance
overexpression of inhA mutation or deletion in katG overexpression of aphC mutations in kasA
28
INH adverse rxns
- hepatitis, age dependent, rare under 20, increased risk w/alcoholics and pregnancy - minor increases in liver aminotransferases (benign) - peripheral neurophathy and other CNS issues due to vit B deficiency, supplementation helps - drug fever - rashes - drug induced SLE
29
INH CI
hepatitis | serious rxns
30
rifampin
readily penetrates into phagocytic cells and can kill organisms that are poorly accessible to other agents
31
rifampin MOA
binds to beta-subunit of DNA dependent RNA polymerase inhibiting RNA synthesis bactericidal
32
rifampin resistance
several points of mutation in rpoB gene
33
rifampin uses
``` mycobacterial infections menigococcal carriers prophylaxis of children exposed to H. influenza B staphylococcal carriers serious staphylococcal infections ```
34
adverse rxns to rifampin
``` strong P450 inducer extreme caution in HIV harmless red/orange color to urine, feces, saliva, sweat, tears, CSF, contact lenses rashes GI thrombocytopenia nephritis hepatotoxicity (not as common as INH) less then 2x/wk flu like symptoms ```
35
pyrazinamide
prodrug converted to pyrazinoic acid by pncA
36
pyrazinamide resistance
imparied uptake of pyrazinamide | mutations in pncA
37
adverse rxns to pyrazinamide
hepatotoxicity (most of all 1st line agents) GI hyperuricemia drug rash (most of all 1st line agents)
38
ethambutol MOA
inhibits mycobacterial arabinosyl transferases encoded by embCAB, essential part of cell wall
39
ethambutol resistance
overexpression of emb gene | mutations w/embB gene
40
adverse rxns ethambutol
retrobulbar neuritis-> loss of visual acuity, red-green color blindness CI in children where acuity and color vision cannot be assessed
41
streptomycin
aminoglycoside | well absorbed as IM, typically administered
42
streptomycin MOA
irreversibly inhibitor of protein synthesis | 30S
43
streptomycin resistance
mutations in rpsL gene mutations in rrs gene TB, MAC, and M. kansasii only mycobacteria that are susceptible
44
streptomycin adverse effects
ototoxicity nephrotoxicity relative CI in prego
45
Second line use for TB
1st line resistance failure w/traditional therapy serious adverse effects of traditional therapy
46
second line drugs
``` ethionamide capreomycin cycloserine aminosalicyli acid (PAS) kanamycin and amikacin FQs linezolid rifabutin rifapentine ```
47
ehtionamide
``` blocks synthesis of mycolic acids oral hepatotoxicity intense GI thyroid and neuro adverse effects single agent -> rapid resistance ```
48
capreomycin
``` peptide protein synthesis inhibitor IM injections resistance due to rrs mutations nephro and ototoxic significant pain and abscesses at injection site ```
49
cycloserine
inhibits cell wall synthesis | peripheral neuropathy and CNS dysfnx
50
aminosalicylic acid
folate synthesis inhibitor active exclusively against TB GI adverse effects severe hypersensativity rxns
51
kanamycin and amikacin
protein synthesis inhibitors amikan less toxic used w/MDR and streptomycin resistant TB adverse effects- nephro and ototoxicity
52
FQs
block bacterial DNA synthesis via DNA gyrase and toposiomerase IV also active against atypical myco resistance due to point mutations in grase A used when resistant to first line agents GI and CNS disturbances can occur impaired glucose control
53
linezolid
significant and potentially life-threatening adverse effects bone marrow suppresion, irreversible peripheral and optic neuropathy rifabutin
54
rifabutin
``` TB MAI M. fortuitum patients with HIV on ARV expensive ```
55
rifapentine
active against TB and MAI
56
M. leprae
dapsone rifampin clofazimine
57
dapsone
similar to sulfonamides, inhibits folate synthesis hemolysis and methemoglobinemia common P. jiroveci in AIDs Tx as well
58
clofazimine
half life up to 2 months sulfone resistant leprosy skin discoloration, GI intolerance
59
M. kansasii clinical
resembles TB
60
M. kansasii Tx
``` cipro clarithromycin ethambutol INH rifampin trimethoprim-sulfamethoxazole ```
61
M. marinum clinical
granulomatous cutaneous disease
62
M. marium Tx
``` Amikacin clarithromycin ethambutol doxycycline minocycline rifampin trimethoprim-sulfamethoxazole ```
63
M. scrofulaceum clinical
cervical adenitis in kids
64
M. scrofulaceum Tx
amikacin, erythromycin, rifampin, streptomycin | surgical excision Tx of choice
65
M. avium complex clinical
pulmonary disease in patients w/chronic lung disease, disseminated in AIDs
66
M. avium complex Tx
``` amikacin azithromycin clarithromycin cipro ethambutol rifabutin ```
67
M. chelonae clinical
abscess sinus ract ulcer bone, joint, or tendon infection
68
M. chelonae Tx
amikacin, doxy, imipenem, macrolide, tobramycin
69
M. fortuitum clinical
abscess sinus ract ulcer bone, joint, or tendon infection
70
M. fortuitum Tx
``` amikacin cefoxitin cipro doxy ofloxacin trimethoprim-sulfamethoxazole ```
71
M. ulcers clinical
skin ulcers
72
M. ulcers Tx
INH, streptomycin, rifampin, minocycline, | surgical excision